Inflammatory markers predict late cardiac events in patients who are exhausted after percutaneous coronary

Martijn Kwaijtaal1, Rob van Diest, Frits W Bär

  • 1Department of Medical Microbiology, University Hospital Maastricht, P. Debeyeplein 25, P.O. Box 5800, 6202 AZ, Maastricht, Limburg, The Netherlands. mkw@lmib.azm.nl

Atherosclerosis
|September 15, 2005
PubMed

Insights

Elevated levels of inflammatory markers like interleukin-6 (IL-6) predict late cardiac events after coronary intervention. These markers, particularly IL-6, show prognostic value and temporal stability in coronary artery disease (CAD) patients.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biomarkers

Background:

  • Chronic inflammation is a key factor in coronary artery disease (CAD) development.
  • Predicting late cardiac events after percutaneous coronary intervention (PCI) is crucial for patient management.

Purpose of the Study:

  • To evaluate the prognostic significance of inflammatory markers for late cardiac events (>6 months post-PCI).
  • To assess the temporal stability of these inflammatory markers over time.

Main Methods:

  • 234 patients undergoing successful PCI were monitored.
  • Serum levels of C-reactive protein (CRP), IL-6, TNF-alpha, IL-10, IL-1ra, IL-8, and neopterin were measured at baseline, 6, and 18 months post-PCI.
  • Cox proportional hazards analysis was used to determine prognostic value for late cardiac events (n=25) over a 24-month follow-up.

Main Results:

  • Elevated baseline IL-6, CRP, and IL-10 predicted increased risk of late cardiac events.
  • Sustained high IL-6 levels at 6 months post-PCI also significantly increased event risk.
  • Elevated IL-1 receptor antagonist (IL-1ra) at 6 months was also associated with higher event risk.
  • Most markers demonstrated high temporal stability, with IL-6 showing the highest stability.

Conclusions:

  • Inflammatory markers, especially IL-6, serve as valuable predictors for late cardiac events following PCI.
  • Chronic inflammation plays a significant role in the pathophysiology and progression of CAD.
  • Monitoring inflammatory markers may aid in risk stratification and personalized treatment strategies for CAD patients.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...